Works matching IS 02724391 AND DT 2021 AND VI 82 AND IP 5

Results: 10

Personalized treatments in neuropsychiatric disorders.

Published in:: Drug Development Research, 2021, v. 82, n. 5, p. 618, doi. 10.1002/ddr.21854
Publication type:: Article

Effect of non‐invasive brain stimulation on behavior and serum brain‐derived neurotrophic factor and insulin‐like growth factor‐1 levels in autistic patients.

Published in:

Drug Development Research, 2021, v. 82, n. 5, p. 716, doi. 10.1002/ddr.21808

By:

Robinson‐Agramonte, Maria de los Angeles;
Michalski, Bernadeta;
Fernández, Lázaro Gomez;
Vidal‐Martinez, Belkis;
Cuesta, Hector Vera;
Rizo, Carlos Maragoto;
Fahnestock, Margaret

Publication type:

Article

Interferon beta 1a (Rebif®) in relapsing remitting multiple sclerosis.

Published in:

Drug Development Research, 2021, v. 82, n. 5, p. 707, doi. 10.1002/ddr.21798

By:

Sánchez, Reinier Cardentey;
de la Fe, Amado Díaz;
Suarez, Alejandro Peláez;
Grass, Dayme;
Vega, Teresa Morgado;
Canal, Armando Sánchez;
Siniscalco, Dario;
de los Angeles Robinson Agramonte, María

Publication type:

Article

Biomarkers to predict staging and treatment response in opioid dependence: A narrative review.

Published in:

Drug Development Research, 2021, v. 82, n. 5, p. 668, doi. 10.1002/ddr.21789

By:

Vorspan, Florence;
Marie‐Claire, Cynthia;
Bellivier, Frank;
Bloch, Vanessa

Publication type:

Article

Influence of dopamine, noradrenaline, and serotonin transporters on the pharmacogenetics of Atremorine in Parkinson's disease.

Published in:

Drug Development Research, 2021, v. 82, n. 5, p. 695, doi. 10.1002/ddr.21784

By:

Cacabelos, Ramón;
Carrera, Iván;
Martínez, Olaia;
Naidoo, Vinogran;
Cacabelos, Natalia;
Aliev, Gjumrakch;
Carril, Juan C.

Publication type:

Article

Anatomical distribution and expression of CYP in humans: Neuropharmacological implications.

Published in:

Drug Development Research, 2021, v. 82, n. 5, p. 628, doi. 10.1002/ddr.21778

By:

Fanni, Daniela;
Pinna, Federica;
Gerosa, Clara;
Paribello, Pasquale;
Carpiniello, Bernardo;
Faa, Gavino;
Manchia, Mirko

Publication type:

Article

Alcohol intake potentiates clozapine adverse effects associated to CYP1A2*1C in patients with refractory psychosis.

Published in:

Drug Development Research, 2021, v. 82, n. 5, p. 685, doi. 10.1002/ddr.21774

By:

Ortega‐Vázquez, Alberto;
Mayen‐Lobo, Yerye G.;
Dávila‐Ortiz de Montellano, David J.;
Tristán‐López, Luis;
Aviña‐Cervantes, Carlos L.;
Ríos, Camilo;
López‐López, Marisol;
Monroy‐Jaramillo, Nancy

Publication type:

Article

Issue Information.

Published in:: Drug Development Research, 2021, v. 82, n. 5, p. 617, doi. 10.1002/ddr.21694
Publication type:: Article

Schizophrenia‐associated gene dysbindin‐1 and tardive dyskinesia.

Published in:

Drug Development Research, 2021, v. 82, n. 5, p. 678, doi. 10.1002/ddr.21681

By:

Maes, Miriam S.;
Lu, Justin Y.;
Tiwari, Arun K.;
Freeman, Natalie;
de Luca, Vincenzo;
Müller, Daniel J.;
Voineskos, Aristotle N.;
Potkin, Steven G.;
Lieberman, Jeffrey A.;
Meltzer, Herbert Y.;
Remington, Gary;
Kennedy, James L.;
Zai, Clement C.

Publication type:

Article

Lithium treatment in the era of personalized medicine.

Published in:: Drug Development Research, 2021, v. 82, n. 5, p. 621, doi. 10.1002/ddr.21660
Publication type:: Article